T. Rowe Price Associates’s AstraZeneca AZN Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.63B | Sell |
51,942,963
-5,143,918
| -9% | -$359M | 0.41% | 35 |
|
|
2025
Q1 | $4.2B | Sell |
57,086,881
-3,265,092
| -5% | -$240M | 0.52% | 31 |
|
|
2024
Q4 | $3.95B | Sell |
60,351,973
-2,540,609
| -4% | -$166M | 0.46% | 35 |
|
|
2024
Q3 | $4.9B | Sell |
62,892,582
-2,047,079
| -3% | -$159M | 0.56% | 30 |
|
|
2024
Q2 | $5.06B | Buy |
64,939,661
+3,667,687
| +6% | +$286M | 0.61% | 24 |
|
|
2024
Q1 | $4.15B | Buy |
61,271,974
+9,002,450
| +17% | +$610M | 0.51% | 31 |
|
|
2023
Q4 | $3.52B | Sell |
52,269,524
-1,475,163
| -3% | -$99.4M | 0.47% | 39 |
|
|
2023
Q3 | $3.64B | Buy |
53,744,687
+899,089
| +2% | +$60.9M | 0.53% | 33 |
|
|
2023
Q2 | $3.78B | Sell |
52,845,598
-5,972,371
| -10% | -$427M | 0.53% | 31 |
|
|
2023
Q1 | $4.08B | Sell |
58,817,969
-9,773,679
| -14% | -$678M | 0.61% | 30 |
|
|
2022
Q4 | $4.65B | Sell |
68,591,648
-6,793,368
| -9% | -$461M | 0.75% | 22 |
|
|
2022
Q3 | $4.14B | Sell |
75,385,016
-10,534,780
| -12% | -$578M | 0.68% | 27 |
|
|
2022
Q2 | $5.68B | Sell |
85,919,796
-8,310,073
| -9% | -$549M | 0.72% | 19 |
|
|
2022
Q1 | $6.25B | Buy |
94,229,869
+4,389,118
| +5% | +$291M | 0.63% | 21 |
|
|
2021
Q4 | $5.23B | Buy |
89,840,751
+7,518,229
| +9% | +$438M | 0.47% | 33 |
|
|
2021
Q3 | $4.94B | Buy |
82,322,522
+14,370,118
| +21% | +$863M | 0.47% | 36 |
|
|
2021
Q2 | $4.07B | Buy |
67,952,404
+9,905,274
| +17% | +$593M | 0.38% | 43 |
|
|
2021
Q1 | $2.89B | Buy |
58,047,130
+39,450,439
| +212% | +$1.96B | 0.29% | 69 |
|
|
2020
Q4 | $930M | Buy |
18,596,691
+2,946,561
| +19% | +$147M | 0.1% | 224 |
|
|
2020
Q3 | $858M | Buy |
15,650,130
+2,040,005
| +15% | +$112M | 0.1% | 212 |
|
|
2020
Q2 | $720M | Buy |
13,610,125
+1,028,613
| +8% | +$54.4M | 0.09% | 230 |
|
|
2020
Q1 | $562M | Buy |
12,581,512
+556,539
| +5% | +$24.9M | 0.09% | 238 |
|
|
2019
Q4 | $600M | Sell |
12,024,973
-214,497
| -2% | -$10.7M | 0.08% | 271 |
|
|
2019
Q3 | $546M | Sell |
12,239,470
-476,475
| -4% | -$21.2M | 0.08% | 259 |
|
|
2019
Q2 | $525M | Buy |
12,715,945
+1,494,435
| +13% | +$61.7M | 0.07% | 272 |
|
|
2019
Q1 | $454M | Sell |
11,221,510
-2,528,992
| -18% | -$102M | 0.07% | 284 |
|
|
2018
Q4 | $522M | Buy |
13,750,502
+565,528
| +4% | +$21.5M | 0.09% | 228 |
|
|
2018
Q3 | $522M | Sell |
13,184,974
-376,100
| -3% | -$14.9M | 0.08% | 262 |
|
|
2018
Q2 | $476M | Sell |
13,561,074
-1,495,134
| -10% | -$52.5M | 0.07% | 263 |
|
|
2018
Q1 | $527M | Buy |
15,056,208
+435,954
| +3% | +$15.2M | 0.08% | 240 |
|
|
2017
Q4 | $507M | Buy |
14,620,254
+370,438
| +3% | +$12.9M | 0.08% | 252 |
|
|
2017
Q3 | $483M | Buy |
14,249,816
+1,867,122
| +15% | +$63.3M | 0.08% | 259 |
|
|
2017
Q2 | $422M | Buy |
12,382,694
+215,625
| +2% | +$7.35M | 0.08% | 280 |
|
|
2017
Q1 | $379M | Buy |
12,167,069
+1,667,384
| +16% | +$51.9M | 0.07% | 288 |
|
|
2016
Q4 | $287M | Buy |
10,499,685
+9,225,595
| +724% | +$252M | 0.06% | 339 |
|
|
2016
Q3 | $41.9M | Buy |
+1,274,090
| New | +$41.9M | 0.01% | 871 |
|
|
2014
Q2 | – | Sell |
-1,467,243
| Closed | -$95.2M | – | 2531 |
|
|
2014
Q1 | $95.2M | Sell |
1,467,243
-436,315
| -23% | -$28.3M | 0.02% | 646 |
|
|
2013
Q4 | $113M | Buy |
1,903,558
+151,820
| +9% | +$9.01M | 0.03% | 580 |
|
|
2013
Q3 | $91M | Buy |
1,751,738
+165,065
| +10% | +$8.57M | 0.02% | 618 |
|
|
2013
Q2 | $75.1M | Buy |
+1,586,673
| New | +$75M | 0.02% | 655 |
|